Montelukast Prescribing at PRIORY MEDICAL GROUP
Cromoglycate, leukotriene and phosphodesterase type-4 inhib | Respiratory System
Items (12m)
3,894
Total Quantity
108.7K
NHS Cost
£5.7K
vs National Avg
+468.7%
PRIORY MEDICAL GROUP prescribed 3,894 items of Montelukast over the last 12 months at a cost of £5,665 to the NHS. This is 468.7% above the national average prescribing rate. Montelukast is classified under Cromoglycate, leukotriene and phosphodesterase type-4 inhib in the BNF.
Monthly Prescribing Trend
Jul 2026
311
Jul 2026
332
Jul 2026
349
Jul 2026
325
Jul 2026
319
Jul 2026
341
Jul 2026
312
Jul 2026
330
Jul 2026
345
Jul 2026
292
Jul 2026
330
Jul 2026
308
Prescribing Details
| Total Items | 3,894 |
|---|---|
| Total Quantity | 108,737 |
| Total NHS Cost | £5,665 |
| Presentations | 4 different forms |
| vs National Average | +468.7% |
Montelukast Prescribing Comparison
| This practice | 3,894 items |
|---|---|
| National average per practice | 685 items |
| Difference | +468.7% vs national average |
Explore More
Data sourced from NHSBSA English Prescribing Dataset, CQC, and GP Patient Survey. Prescribing data does not indicate quality of care. Higher prescribing rates may reflect patient demographics. Always consult your GP for medical advice.